India’s healthcare simulation market is growing rapidly, and Maverick Simulation Solutions might have started gaining attention in the unlisted sector due to its strong financial growth and niche medtech positioning. In this blog of Maverick Simulation Solutions Share Price Target will uncover:

• What Does Maverick Simulation Solutions Do?

• What Products Does Maverick Simulation Solutions Offer?

• Who Are The Key Investors And Funding Rounds For Maverick Simulation?

• Maverick Simulations Solutions Unlisted Share price Valuation 2026

• Maverick Simulation Solutions Unlisted Share Price Valuation 2026

• Maverick Simulation Solutions IPO

What Does Maverick Simulation Solutions Do?

Maverick Simulation Solutions is an Indian medtech company based in New Delhi that develops medical simulation and healthcare training solutions for medical colleges, hospitals, nursing institutes, and skill development centres. The company focuses on improving clinical education through hands-on, risk-free training technologies. 

Maverick follows a strong “Made in India” approach, focusing on in-house R&D, affordable innovation, and reducing reliance on imported medical simulation equipment while supporting India’s growing healthcare education ecosystem.

What Products Does Maverick Simulation Solutions Offer?

Maverick Simulation Solutions primarily offers medical simulation and healthcare training products designed for hospitals, medical colleges, nursing institutes, and clinical training centres. The company positions itself as a medtech and simulation-training provider focused on improving clinical education, patient safety, and hands-on medical learning in India. Their key product categories include:

A. Core Products

• Patient Simulators

High-fidelity adult, neonatal, and critical care simulators for clinical training.

• Autonomous Human Lung Simulators

Products like LuSi and TestChest for respiratory and ventilator training.

• Surgical Simulators

Tools for procedural and surgical practice.

• Virtual Anatomy Dissection Tables 

Interactive digital anatomy learning systems.

• Task Trainers

Hands-on skill trainers for injections, suturing, airway management, catheterisation, vascular access, and more.

• Medical Manikins

CPR mannequins, IV training arms, infant IO legs, airway trainers, and examination models.

• Gynaecological & Breast Examination Models

Training simulators for clinical examination practice.

B. Advanced Simulation Platforms

• Leonardo Adult Patient Simulator

A high-fidelity simulator with ECG, airway, breathing, CPR, and ultrasound integration capabilities.

• SIDDH Critical Care Simulator

AI-powered critical care simulator with lung simulation and ultrasound technology.

C. Training & Education Services

Through Maverick SimAcademy, the company also provides simulation-based healthcare training programmes such as:

• IVFSim PRO

• NurseSim PRO

• Clinical simulation courses for doctors and nurses.

Who Are The Key Investors And Funding Rounds For Maverick Simulation?

Innovations Venture Studio is the primary publicly known investor in Maverick Simulation Solutions. The venture studio acquired a 12.5% stake in the company through a strategic growth investment. The aim is to support expansion, product innovation, and global market entry. The investment platform itself is backed by firms such as Vencap Advisory and LMD2 Innovative Advisors, giving Maverick access to both capital and strategic business guidance.

Apart from this investment, the company remains largely promoter-driven. The key promoters and major shareholders include Anuj Chahal, Kanika Chahal, and Sunil Tomar, who together continue to hold a majority stake in the company. As of now, there are no publicly disclosed investments from large venture capital firms, private equity funds, or prominent angel investors.

Promoters & Major Shareholders 

In 2023, Innovations Venture Studio made a strategic growth investment in Maverick Simulation Solutions by acquiring a 12.5% stake in the company. The funding was aimed at helping Maverick expand its operational infrastructure, accelerate product development, strengthen its medical simulation technologies, and support global expansion plans, mainly in North America.

Beyond external funding, the company also announced an internal R&D investment of over Rs.50 cr in 2025 to develop next-generation healthcare training technologies. This investment is focused on AI-integrated simulators, advanced task trainers, and critical care simulation platforms.

As of now, there is no public evidence of Maverick Simulation Solutions raising traditional startup funding rounds such as seed, Series A, or Series B investments. The company currently likely has no backing from major VC or private equity firms, with the Innovations Venture Studio stake acquisition being its only publicly disclosed funding activity. 

Maverick Simulations Solutions Unlisted Share price Valuation 2026

Maverick Simulation Solutions revenue rose nearly 97% from Rs. 70.5 cr. in FY24 to Rs. 138.9 cr. in FY25. 

EBITDA also jumped sharply from Rs. 26.6 cr. to Rs. 64.2 cr., while EBITDA margins improved from 37.7% to 46.2%, reflecting better operational efficiency and stronger pricing power. 

Net profit increased from Rs. 19.7 cr. to Rs. 47.8 cr., and EPS increased to Rs. 97.32, indicating improving profitability and scalability.

The current Maverick Simulations Solutions unlisted share price is around Rs. 2,600. In terms of valuation, the company commands an estimated market capitalisation of nearly Rs. 1,175 cr. The stock is currently trading at a PE multiple of around 59.7x and a Price-to-Book ratio of 26.6x, suggesting that investors might be pricing in strong future growth expectations.

Given the company’s niche presence in the medical simulation and healthcare training segment, along with rising margins and high ROE of 45%, Maverick Simulation Solutions could possibly continue attracting investor interest in the unlisted market. However, the current valuation already reflects significant optimism, and future performance, scalability, and any potential IPO developments will likely play a key role in determining further upside.

Maverick Simulation Solutions IPO

Maverick Simulation Solutions has not officially launched its IPO process yet, and the company has not filed a DRHP with SEBI so far. There might also be no confirmed IPO size, valuation, or listing timeline available publicly. However, the company has likely been gaining attention in the unlisted market, leading to speculation about a possible potential future IPO as interest in India’s medtech sector might continue to grow.